Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CHRND | Q07001 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11492383 | 0.98 | CNR1 (0.44) | CNR1CNR2TAAR1HTR3ATSHR | |
| Hydrochloric Acid SCHEMBL11490445 | 0.85 | CNR1 (0.44) | CNR1CNR2TAAR1HTR3ATSHR | |
| SCHEMBL11480826 | 0.81 | HPGD (0.46) | CNR1CNR2KDM4E | |
| SCHEMBL2944289 | 0.81 | CNR1 (0.41) | CNR1CNR2 | |
| SCHEMBL27538428 | 0.81 | CNR1 (0.41) | CNR1CNR2 | |
| SCHEMBL9328613 | 0.81 | ESR1 (0.42) | CNR1CNR2TAAR1HIF1AKDM4E | |
| SCHEMBL11485573 | 0.80 | ALDH1A1 (0.48) | CNR1CNR2TSHRNFKB1KDM4E | |
| SCHEMBL11488043 | 0.79 | SLC7A5 (0.43) | — | |
| Hydrochloric Acid SCHEMBL11480409 | 0.78 | SLC7A5 (0.42) | — | |
| Hydrochloric Acid SCHEMBL11482322 | 0.78 | CNR1 (0.41) | CNR1CNR2HIF1AKDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9109090-B2 | Amino acid-modified organopolysiloxane, making method, and cosmetics | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2441790-B1 | Amino acid-modified organopolysiloxane, making method, and cosmetics | SHINETSU CHEMICAL CO (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-20120093746-A1 | AMINO ACID-MODIFIED ORGANOPOLYSILOXANE, MAKING METHOD, AND COSMETICS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-2441790-A1 | Amino acid-modified organopolysiloxane, making method, and cosmetics | Shin-Etsu Chemical Co., Ltd. (JP) | 2012-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120093746-A1 | AMINO ACID-MODIFIED ORGANOPOLYSILOXANE, MAKING METHOD, AND COSMETICS | DAO, AADAT, BCAT2 | CNR1 4795/4885CNR2 4816/4885TAAR1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.